| Systematic (IUPAC) name | |
|---|---|
| (6aR,10aR)-3-(1-hexylcyclopentyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 10982174 |
| ChemSpider | 9157375 |
| ChEMBL | CHEMBL108868 |
| Chemical data | |
| Formula | C27H40O2 |
| Mol. mass | 396.604 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
AMG-36 is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8THC substituted with a cyclopentane group on the 3-position side chain. AMG-36 is a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 0.4nM at CB1 vs 1.9nM at CB2.[1][2]
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)